SANJEEV VASUDEVAN to Proto-Oncogene Proteins c-abl
This is a "connection" page, showing publications SANJEEV VASUDEVAN has written about Proto-Oncogene Proteins c-abl.
Connection Strength
0.137
-
Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling. Oncotarget. 2017 Jan 03; 8(1):1469-1480.
Score: 0.137
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.